KIDSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
ORTHOPEDIATRICS CORP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$22.03+0.08 (+0.36%)
Close on Oct 19, 2026
- Market cap
- $529.79M
- P/E (TTM)
- –
- Dividend yield
- –
Orthopediatrics statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | Orthopediatrics | Industry median |
|---|---|---|
| Market Cap | $575.20M | $230.55M |
| Enterprise Value | $631.31M | $202.97M |
| PS Ratio | 2.28 | 3.10 |
| PB Ratio | 1.67 | 3.04 |
| P/TBV Ratio | 3.56 | 4.43 |
| P/OCF Ratio | 77.65 | 22.47 |
Enterprise value
| Measure | Orthopediatrics | Industry median |
|---|---|---|
| EV / Sales | 2.50 | 2.91 |
Income (trailing twelve months)
| Measure | Orthopediatrics | Industry median |
|---|---|---|
| Revenue | $252.73M | $102.39M |
| Gross Profit | $186.14M | $60.36M |
| Operating Income | -$30.00M | -$4.31M |
| Pretax Income | -$39.45M | -$2.37M |
| Net Income | -$39.73M | -$6.57M |
| EBITDA | -$7.68M | -$1.98M |
| EPS (Diluted) | -$1.68 | -$0.08 |
Margins
| Measure | Orthopediatrics | Industry median |
|---|---|---|
| Gross Margin | 73.7% | 55.2% |
| Operating Margin | -11.9% | -6.04% |
| Pretax Margin | -15.6% | -4.11% |
| Profit Margin | -15.7% | -10.5% |
| EBITDA Margin | -3.04% | -2.67% |
| FCF Margin | -0.73% | 0.02% |
Returns
| Measure | Orthopediatrics | Industry median |
|---|---|---|
| Return on Equity (ROE) | -11.4% | -18.2% |
| Return on Assets (ROA) | -7.83% | -13.3% |
| Return on Invested Capital (ROIC) | -6.07% | -3.69% |
| Return on Capital Employed (ROCE) | -6.54% | -9.07% |
Growth
| Measure | Orthopediatrics | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 14.5% | 8.85% |
| Revenue Growth (3Y CAGR) | 24.6% | 7.08% |
| Revenue Growth (5Y CAGR) | 27.2% | 11.8% |
Balance sheet
| Measure | Orthopediatrics | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $45.88M | $36.66M |
| Total Debt | $101.99M | $97.65M |
| Net Cash (Debt) | -$56.11M | $3.92M |
| Net Cash Per Share | -$2.15 | $0.28 |
| Equity (Book Value) | $343.61M | $55.33M |
| Book Value Per Share | $13.16 | $2.87 |
| Tangible Book Value | $161.41M | $10.79M |
| Working Capital | $199.66M | $56.72M |
Financial position
| Measure | Orthopediatrics | Industry median |
|---|---|---|
| Current Ratio | 4.78 | 2.48 |
| Quick Ratio | 2.02 | 1.53 |
| Debt / Equity | 0.30 | 0.41 |
| Interest Coverage | -3.58 | -1.85 |
Cash flow (trailing twelve months)
| Measure | Orthopediatrics | Industry median |
|---|---|---|
| Operating Cash Flow | $7.41M | -$566.22K |
| Capital Expenditures | -$9.24M | -$3.69M |
| Free Cash Flow | -$1.84M | -$696.00K |
| FCF Per Share | -$0.07 | -$0.02 |
Efficiency
| Measure | Orthopediatrics | Industry median |
|---|---|---|
| Asset Turnover | 0.50 | 0.58 |
| Inventory Turnover | 0.51 | 2.21 |
| Revenue Per Employee | $419.81K | $322.92K |
| Profits Per Employee | -$65.99K | -$51.88K |
| Employee Count | 602 | 185 |
Dividends and yields
| Measure | Orthopediatrics | Industry median |
|---|---|---|
| Earnings Yield | -6.91% | -6.88% |
| FCF Yield | -0.32% | -0.45% |
Shares
| Measure | Orthopediatrics | Industry median |
|---|---|---|
| Shares Outstanding | 26,109,800 | 44,302,700 |
| Shares Change (YoY) | 1.98% | 3.36% |
| Float | 18,228,100 | 37,462,700 |
| Shares Held by Insiders | 30.2% | 10.5% |
| Shares Held by Institutions | 64.3% | 63.5% |
Taxes
| Measure | Orthopediatrics | Industry median |
|---|---|---|
| Income Tax | $278.00K | $1.52M |
Scores
| Measure | Orthopediatrics | Industry median |
|---|---|---|
| Altman Z-Score | 2.02 | 1.95 |
| Piotroski F-Score | 4 | 5 |
| Beneish M-Score | -2.66 | -2.64 |
Calculated by StockData from Orthopediatrics's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.